PREMIUM
GRACE PAUL
Madrid
Monday, March 1, 2021 - 02:28
Share on Facebook
Share on Twitter
Send by email
Live.
Coronavirus, live
Graphic.
This is how vaccination progresses, CCAA by CCAA
The question is common among those who receive the long-awaited appointment to be vaccinated, "which one are you going to get?".
In Spain, three possibilities are already being considered: that of Pfizer, that of Moderna and that which seems to be the least popular (at least in neighboring countries), that of AstraZeneca. Vaccines licensed so far present
spectacular efficacy data in their clinical trials
.
Somewhat more variable in disease prevention
Become Premium and
enjoy 3 months for € 1
Take advantage of this limited time offer and access all web content
I love you
Are you already Premium?
Log in
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more